At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.

Research Grants 67 show all


$23.6M
2013

$12.6M
2014

$23.5M
2015

$1.9M
2016

$648.9K
2018

Patents 26,159show all

  • 8,440
    C07K - Peptides
  • 7,529
    A61K - Preparations for medical, dental, or toilet purposes
  • 2,628
    C12N - Microorganisms or enzymes
  • 2,318
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 1,202
    C07D - Heterocyclic compounds
  • 1,051
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 492
    A01K - Animal husbandry
  • 492
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 416
    C12Y - Enzymes
  • 392
    Y02A - Technologies for adaptation to climate change

Clinical Trials 1,653show all

725Phase 2321Phase 1155N/A146Phase 3121Phase 1/Phase 291Other

SEC Filings show all


64
8-K

43
10-Q

13
10-K

Contact Information

South San Francisco, CA
United States